Dihydrocodeine bitartrate 16 mg / acetaminophen 356.4 mg / caffeine 30 mg Oral Capsule
RxNorm 1234871
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1234871 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: dihydrocodeine bitartrate 16 mg / acetaminophen 356.4 mg / caffeine 30 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Acetaminophen 356.4 mg / caffeine 30 mg / dihydrocodeine bitartrate 16 mg Oral Capsule
(Atom ID: 12332660)
PT
Designated preferred name (PT):
Acetaminophen 356.4 mg and caffeine 30 mg and dihydrocodeine tartrate 16 mg oral capsule
(Atom ID: 10293174)
SY
Synonym (SY):
APAP 356.4 mg / caffeine 30 mg / dihydrocodeine bitartrate 16 mg Oral Capsule
(Atom ID: 4224998)
SY
Synonym (SY):
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule
(Atom ID: 10295300)
PSN
Prescribable Name (PSN):
Dihydrocodeine bitartrate 16 mg / acetaminophen 356.4 mg / caffeine 30 mg Oral Capsule
(Atom ID: 6360383)
FN